C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter A—GeneralPart 7—Enforcement PolicySubpart C—Recalls (Including Product Corrections)—Guidance on Policy, Procedures, and Industry Responsibilities

21 C.F.R. § 7.41 (2026)

Health hazard evaluation and recall classification

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1995–2018 8citing cases
At a glance

Courts have cited this section in 8 opinions since 1995. The most litigated part is subsection (b) (1 case).

(a) An evaluation of the health hazard presented by a product being recalled or considered for recall will be conducted by an ad hoc committee of Food and Drug Administration scientists and will take into account, but need not be limited to, the following factors:

(1) Whether any disease or injuries have already occurred from the use of the product.

(2) Whether any existing conditions could contribute to a clinical situation that could expose humans or animals to a health hazard. Any conclusion shall be supported as completely as possible by scientific documentation and/or statements that the conclusion is the opinion of the individual(s) making the health hazard determination.

(3) Assessment of hazard to various segments of the population, e.g., children, surgical patients, pets, livestock, etc., who are expected to be exposed to the product being considered, with particular attention paid to the hazard to those individuals who may be at greatest risk.

(4) Assessment of the degree of seriousness of the health hazard to which the populations at risk would be exposed.

(5) Assessment of the likelihood of occurrence of the hazard.

(6) Assessment of the consequences (immediate or long-range) of occurrence of the hazard.

(b) On the basis of this determination, the Food and Drug Administration will assign the recall a classification, i.e., Class I, Class II, or Class III, to indicate the relative degree of health hazard of the product being recalled or considered for recall.

The 8 cases that cite 21 C.F.R. § 7.41 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENBanfi Prods. Corp. v. United States, 40 Fed. Cl. 107 (Fed. Cl. 1997).
cites § 7.41 5×subsections: (b)cited by 10 cases
Where it cites § 7.41
“7 21 C.F.R. § 7.41 (a). At the time relevant to this case, the ad hoc committee consisted of scientists working at CFSAN, was known as the Health Hazard Evaluation Board (HHEB), and its reports were called Health Hazard Evaluations (HHE).”
2
GREENWash. Cnty. Health Care Auth., Inc. v. Baxter Int'l Inc., 328 F. Supp. 3d 824 (E.D. Ill. 2018).
cites § 7.41 2×cited by 5 cases
Where it cites § 7.41
“" 21 C.F.R. § 7.41 (a). In so doing, the FDA evaluates "whether any existing conditions could contribute to a clinical situation that could expose humans or animals to a health hazard," and assesses the likelihood and seriousness of the consequences posed by the hazard.”
3
GREENClark v. Actavis Grp. HF, 567 F. Supp. 2d 711 (D.N.J. 2008).
cites § 7.41 1×cited by 3 cases
Where it cites § 7.41
“See 21 C.F.R. §§ 7.41 (a)-(b) (2008). In collaboration with the recalling firm, the FDA “review[s] the adequacy of a proposed recall strategy developed by a recalling firm and recommend[s] changes as appropriate.”
4
NEUTRALGates v. Medtronic, Inc., 192 F. Supp. 3d 704 (W.D. Tex. 2016).
cites § 7.41 2×cited by 1 case
Where it cites § 7.41
“§ 360h(e)(2) (granting FDA authority over device recall orders and timetables); see also 21 C.F.R. § 7.41 (b) (describing FDA methodology in assessing device recall classification).”
5
GREENFisher Bros. Sales v. United States, 46 F.3d 279 (3d Cir. 1995).
cites § 7.41 2×cited by 1 caseunknown
Where it cites § 7.41
“" 21 C.F.R. § 7.41 (a)(4),(5). already been conducted, the probability that contaminated grapes, if they existed, would be consumed, and probable consequences of any such consumption to the person poisoned, fruit consumers in general, and to the fruit industry as a whole.”
6
NO FLAGWashington Cnty. Health Care Auth., Inc. v. Baxter Int'l Inc., No. 1:16-cv-10324 (N.D. Ill. July 5, 2018).
cites § 7.41 1×cited by 0 casesunknown
Where it cites § 7.41
“21 C.F.R. § 7.41 (b). As the defendants point out, by initiating a fake recall in furtherance of an illegal agreement to restrict output would invite—require, actually—the government to scrutinize the artifice through which the unlawful collusion occurred.”
7
NO FLAGALZA Corp. v. Doris Thompson, No. 13-07-00090-CV, 2010 WL 1254610 (Tex. App.—Corpus Christi Apr. 1, 2010).
cites § 7.41 1×cited by 0 cases
Summary
No passage or summary on file for this case yet.
8
NO FLAGALZA Corp. v. Doris Thompson, No. 13-07-00090-CV (Tex. App.—Corpus Christi Apr. 1, 2010).
cites § 7.41 1×cited by 0 cases
Summary
No passage or summary on file for this case yet.

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
199520062018

One bar per year. Tallest: 2 cases in 2010. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
Tex. App.23rd Cir.1E.D. Ill.1N.D. Ill.1D.N.J.1W.D. Tex.1Fed. Cl.1
By subsection
(b)1 case
Banfi Prods. Corp. v. United States, 40 Fed. Cl. 107 (Fed. Cl. 1997).“7 21 C.F.R. § 7.41 (a). At the time relevant to this case, the ad hoc committee consisted of scientists working at CFSAN, was known as the Health Hazard Evaluation Board (HHEB), and its reports were called Health Hazard Evaluations (HHE).”
Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com